Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Total Current Liabilities (2016 - 2020)

Historic Total Current Liabilities for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to $5.2 million.

  • Larimar Therapeutics' Total Current Liabilities fell 6830.9% to $5.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was $5.2 million, marking a year-over-year decrease of 6830.9%. This contributed to the annual value of $5.9 million for FY2019, which is 5569.67% down from last year.
  • Larimar Therapeutics' Total Current Liabilities amounted to $5.2 million in Q3 2020, which was down 6830.9% from $6.6 million recorded in Q2 2020.
  • In the past 5 years, Larimar Therapeutics' Total Current Liabilities registered a high of $16.3 million during Q3 2019, and its lowest value of $5.2 million during Q3 2020.
  • Over the past 5 years, Larimar Therapeutics' median Total Current Liabilities value was $9.9 million (recorded in 2020), while the average stood at $10.0 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 8409.55% in 2019, then crashed by 6830.9% in 2020.
  • Larimar Therapeutics' Total Current Liabilities (Quarter) stood at $9.9 million in 2016, then decreased by 26.29% to $7.3 million in 2017, then soared by 82.45% to $13.3 million in 2018, then plummeted by 55.7% to $5.9 million in 2019, then dropped by 12.16% to $5.2 million in 2020.
  • Its Total Current Liabilities stands at $5.2 million for Q3 2020, versus $6.6 million for Q2 2020 and $9.9 million for Q1 2020.